Member Login
  1. Stocks
    2. /
  2. Shield Therapeutics plc (LSE: STX)
    3. /

LSE:STX (Shield Therapeutics plc)

About STX

Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialization of late stage, hospital-focused pharmaceuticals which address areas of high unmet medical need. The company's operating segments which is based on key products include Feraccru, used as a novel oral treatment for iron deficiency anemia in patients, which is commercially available and PT20 used in treating hyperphosphatemia, which is in its last stage of completion. It generates maximum revenue from Feraccru segment.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Shield Therapeutics plc (LSE: STX) Latest News

    Investing Articles

    Should I buy these 2 penny stocks?

    | Royston Wild

    News coming out of these low-cost UK shares has been encouraging in recent months. Is now the time for me…

    Read more »

    Investing Articles

    Here are two UK small-cap stocks I’d buy right now

    | James J. McCombie

    Uk small-cap stocks can offer great returns but are often very risky. I think these two shares are worth a…

    Read more »

    Investing Articles

    Why I’d ditch this high-risk growth share to buy British American Tobacco plc

    | Roland Head

    After a sharp decline, British American Tobacco plc (LON:BATS) could be worth a fresh look.

    Read more »

    Investing Articles

    Is Shield Therapeutics plc a better bet than AstraZeneca plc?

    | Alan Oscroft

    Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN)…

    Read more »